Article
Uncoding the genetic heterogeneity of myelodysplastic syndrome.
Hematology. American Society of Hematology. Education Program - 8 Dec 2017
Lindsley R Coleman
Abstract excerpt
Myelodysplastic syndrome (MDS) is a clinically heterogeneous disease characterized by functional impairment of hematopoiesis and abnormal bone marrow morphology. The type and severity of hematopoietic dysfunction in MDS are highly variable, and the kinetics of disease progression are difficult to predict. Genomic studies have shown that MDS is typically driven by a multistep somatic genetic process affecting a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
